| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 11 | 2014 | 1108 | 1.200 |
Why?
|
| Thyroglobulin | 6 | 2007 | 65 | 1.010 |
Why?
|
| Thyroiditis, Autoimmune | 4 | 2007 | 36 | 0.680 |
Why?
|
| Myocarditis | 3 | 2008 | 195 | 0.590 |
Why?
|
| Multiple Myeloma | 14 | 2014 | 2321 | 0.540 |
Why?
|
| Osteoclasts | 3 | 2013 | 158 | 0.530 |
Why?
|
| Autoimmune Diseases | 3 | 2008 | 425 | 0.530 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 37 | 0.520 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 70 | 0.510 |
Why?
|
| Zinc Fingers | 1 | 2016 | 222 | 0.490 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 187 | 0.490 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 274 | 0.480 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 233 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 491 | 0.450 |
Why?
|
| Bone Marrow Cells | 4 | 2016 | 985 | 0.420 |
Why?
|
| Sequence Deletion | 1 | 2016 | 909 | 0.420 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 71 | 0.420 |
Why?
|
| Iodine | 3 | 2007 | 55 | 0.400 |
Why?
|
| Peyer's Patches | 1 | 2011 | 31 | 0.390 |
Why?
|
| Immune Tolerance | 3 | 2013 | 425 | 0.380 |
Why?
|
| Bone and Bones | 2 | 2016 | 612 | 0.380 |
Why?
|
| Mice | 35 | 2016 | 35992 | 0.380 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 162 | 0.360 |
Why?
|
| Autoantigens | 3 | 2007 | 245 | 0.350 |
Why?
|
| Receptor Cross-Talk | 1 | 2010 | 82 | 0.350 |
Why?
|
| RNA, Messenger | 3 | 2012 | 6483 | 0.340 |
Why?
|
| Thyroid Gland | 3 | 2007 | 370 | 0.340 |
Why?
|
| Interleukin-9 | 3 | 2014 | 37 | 0.340 |
Why?
|
| Lymphocyte Activation | 5 | 2010 | 1733 | 0.330 |
Why?
|
| Bone Marrow | 3 | 2016 | 2434 | 0.330 |
Why?
|
| Cell Differentiation | 10 | 2014 | 4191 | 0.320 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 289 | 0.320 |
Why?
|
| Immune System | 1 | 2010 | 276 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2014 | 1654 | 0.310 |
Why?
|
| Interferon-alpha | 2 | 2011 | 960 | 0.300 |
Why?
|
| Sodium Iodide | 1 | 2007 | 1 | 0.290 |
Why?
|
| Melanoma, Experimental | 3 | 2014 | 385 | 0.290 |
Why?
|
| Monoiodotyrosine | 1 | 2007 | 1 | 0.290 |
Why?
|
| Goiter | 1 | 2007 | 17 | 0.290 |
Why?
|
| Lymphocytes | 2 | 2008 | 1269 | 0.270 |
Why?
|
| Animals | 36 | 2016 | 62771 | 0.270 |
Why?
|
| Antigens | 1 | 2006 | 288 | 0.250 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 7461 | 0.250 |
Why?
|
| Hypothyroidism | 1 | 2007 | 211 | 0.250 |
Why?
|
| Mice, Inbred CBA | 5 | 2007 | 83 | 0.240 |
Why?
|
| Tyrosine | 1 | 2006 | 510 | 0.240 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2014 | 1053 | 0.240 |
Why?
|
| Epitopes | 1 | 2007 | 711 | 0.240 |
Why?
|
| Thymus Gland | 1 | 2005 | 310 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1730 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 3 | 2013 | 746 | 0.210 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 219 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 1538 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 1773 | 0.200 |
Why?
|
| beta 2-Microglobulin | 2 | 2014 | 189 | 0.200 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1522 | 0.200 |
Why?
|
| Cancer Vaccines | 3 | 2012 | 750 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2012 | 426 | 0.190 |
Why?
|
| Mice, SCID | 10 | 2014 | 1855 | 0.190 |
Why?
|
| Peptides | 1 | 2007 | 1529 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 349 | 0.180 |
Why?
|
| Major Histocompatibility Complex | 3 | 2010 | 92 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 209 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2012 | 2906 | 0.170 |
Why?
|
| Diet | 1 | 2007 | 1485 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 7216 | 0.160 |
Why?
|
| Apoptosis | 8 | 2014 | 7847 | 0.160 |
Why?
|
| Cell Lineage | 2 | 2012 | 706 | 0.140 |
Why?
|
| B-Lymphocytes | 4 | 2012 | 1424 | 0.140 |
Why?
|
| B7-H1 Antigen | 2 | 2014 | 1057 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 1372 | 0.140 |
Why?
|
| Cytokines | 5 | 2014 | 2836 | 0.140 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 2014 | 635 | 0.130 |
Why?
|
| Side-Population Cells | 1 | 2016 | 17 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2014 | 1838 | 0.130 |
Why?
|
| Antigens, Neoplasm | 3 | 2012 | 1589 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 4510 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2014 | 1184 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 4182 | 0.120 |
Why?
|
| Gene Expression | 3 | 2016 | 3681 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 512 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 9078 | 0.120 |
Why?
|
| Macrophages | 2 | 2012 | 1368 | 0.120 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 88 | 0.120 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 45 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2014 | 1076 | 0.110 |
Why?
|
| Immunity, Cellular | 2 | 2012 | 442 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2016 | 831 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 435 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2014 | 245 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 1146 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 7 | 2014 | 5834 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 203 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2012 | 289 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2016 | 1187 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2014 | 224 | 0.110 |
Why?
|
| CD11c Antigen | 1 | 2012 | 57 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2012 | 65 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2012 | 87 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 3928 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2016 | 606 | 0.100 |
Why?
|
| Leukocyte Common Antigens | 1 | 2012 | 192 | 0.100 |
Why?
|
| P-Selectin | 1 | 2012 | 110 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 233 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2012 | 140 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2007 | 1329 | 0.100 |
Why?
|
| Osteolysis | 1 | 2012 | 99 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 337 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 3655 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2013 | 248 | 0.090 |
Why?
|
| Vaccines, DNA | 1 | 2011 | 111 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2012 | 143 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2014 | 1021 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 631 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 227 | 0.090 |
Why?
|
| Leukopoiesis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2016 | 5837 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 97 | 0.090 |
Why?
|
| Chemokine CXCL2 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Morpholines | 1 | 2011 | 297 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2012 | 394 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2011 | 223 | 0.090 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 371 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2011 | 163 | 0.090 |
Why?
|
| Cell Proliferation | 8 | 2014 | 7294 | 0.090 |
Why?
|
| Granulocytes | 1 | 2010 | 243 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 161 | 0.080 |
Why?
|
| Mice, Inbred ICR | 2 | 2007 | 246 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2011 | 380 | 0.080 |
Why?
|
| Dexamethasone | 2 | 2011 | 1506 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 61 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 228 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2008 | 16 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 595 | 0.080 |
Why?
|
| Interleukin-10 | 4 | 2013 | 481 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 673 | 0.080 |
Why?
|
| HLA-A2 Antigen | 1 | 2009 | 171 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 696 | 0.070 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1030 | 0.070 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 1107 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 253 | 0.070 |
Why?
|
| Tumor Microenvironment | 3 | 2014 | 2984 | 0.070 |
Why?
|
| Thyroiditis | 1 | 2007 | 19 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2008 | 260 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 770 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 79 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 665 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1574 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 852 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2335 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2014 | 12206 | 0.070 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 113 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 570 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2014 | 246 | 0.070 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2011 | 841 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 3648 | 0.060 |
Why?
|
| Cell Survival | 4 | 2014 | 3081 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 715 | 0.060 |
Why?
|
| Neutrophils | 1 | 2010 | 870 | 0.060 |
Why?
|
| Mice, Inbred NOD | 3 | 2014 | 911 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 5438 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1215 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2006 | 267 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 1230 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 603 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2006 | 268 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 14864 | 0.060 |
Why?
|
| Biomarkers | 1 | 2016 | 5106 | 0.060 |
Why?
|
| Cell Communication | 3 | 2014 | 515 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3416 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 4644 | 0.050 |
Why?
|
| Antibodies | 1 | 2006 | 835 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2005 | 860 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 2214 | 0.050 |
Why?
|
| Myocardium | 1 | 2008 | 1249 | 0.050 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 2012 | 57 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 2465 | 0.050 |
Why?
|
| Humans | 18 | 2014 | 270947 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 1145 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3349 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 6789 | 0.050 |
Why?
|
| Female | 10 | 2014 | 148509 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 5411 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2012 | 5494 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2012 | 3083 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 5782 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 594 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2014 | 683 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 3536 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2012 | 593 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 774 | 0.040 |
Why?
|
| Melphalan | 2 | 2012 | 877 | 0.040 |
Why?
|
| Stromal Cells | 2 | 2013 | 840 | 0.040 |
Why?
|
| Prognosis | 1 | 2016 | 22458 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2012 | 609 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 4840 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 2261 | 0.030 |
Why?
|
| Vaccination | 2 | 2011 | 1147 | 0.030 |
Why?
|
| Melanoma | 1 | 2012 | 5523 | 0.030 |
Why?
|
| Liver | 1 | 2005 | 3126 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5161 | 0.030 |
Why?
|
| Immunotherapy | 3 | 2012 | 3532 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2014 | 106 | 0.030 |
Why?
|
| Male | 8 | 2014 | 128454 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3920 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2014 | 137 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2014 | 313 | 0.030 |
Why?
|
| Receptors, CCR6 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2012 | 21 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 736 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2012 | 76 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 87 | 0.030 |
Why?
|
| Receptors, OX40 | 1 | 2011 | 51 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 170 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 153 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 173 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 161 | 0.020 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 68 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 1567 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 83 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 294 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 504 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 311 | 0.020 |
Why?
|
| Receptors, Interleukin-8 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 339 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 55 | 0.020 |
Why?
|
| Thalidomide | 1 | 2014 | 600 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 61 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 116 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2014 | 670 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 201 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 316 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 11761 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 688 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 787 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 704 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1084 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1398 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 147 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14679 | 0.020 |
Why?
|
| Myosins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1212 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 916 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1369 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 616 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 191 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 686 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 1088 | 0.020 |
Why?
|
| Hybridomas | 1 | 2007 | 72 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 403 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 2474 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 887 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 689 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 3231 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 459 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1603 | 0.020 |
Why?
|
| Caspases | 1 | 2008 | 698 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1725 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 592 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 1583 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 843 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 196 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1834 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 1436 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2151 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3245 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6027 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4371 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2399 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6465 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3067 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33827 | 0.010 |
Why?
|